We are live on ! Find out more
Jacobs Levy Equity Management

Jacobs Levy Equity Management Portfolio holdings

AUM $23.8B
1-Year Est. Return 25.4%
This Fund
S&P 500
This Quarter Est. Return
+10.19%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$10.2B
AUM Growth
+$2.04B
Cap. Flow
+$1.34B
Cap. Flow %
13.16%
Top 10 Hldgs %
16.92%
Holding
1,109
New
201
Increased
523
Reduced
236
Closed
122

Sector Composition

Rank Sector Weight
1 Technology 19.58%
2 Financials 15.64%
3 Healthcare 14.3%
4 Consumer Discretionary 12.01%
5 Industrials 9.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRKS icon
726
United Parks & Resorts
PRKS
$2.11B
$795K 0.01%
25,080
-720
-3% -$20.8K
TRIP icon
727
TripAdvisor
TRIP
$1.59B
$794K 0.01%
+26,144
New +$880K
FBIZ icon
728
First Business Financial Services
FBIZ
$562M
$792K 0.01%
30,067
+7,564
+34% +$188K
PAGP icon
729
Plains GP Holdings
PAGP
$5.23B
$752K 0.01%
39,708
-90,092
-69% -$1.69M
ENPH icon
730
Enphase Energy
ENPH
$4.84B
$749K 0.01%
28,675
MCHX icon
731
Marchex
MCHX
$79.7M
$746K 0.01%
197,485
-57,888
-23% -$208K
FSP
732
Franklin Street Properties
FSP
$44.8M
$739K 0.01%
86,283
+20,783
+32% +$179K
CHUY
733
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
$733K 0.01%
28,287
+10,052
+55% +$260K
PDFS icon
734
PDF Solutions
PDFS
$2.13B
$725K 0.01%
+42,937
New +$659K
BSET icon
735
Bassett Furniture
BSET
$169M
$724K 0.01%
43,391
+24,104
+125% +$374K
STRO icon
736
Sutro Biopharma
STRO
$379M
$719K 0.01%
6,533
+3,454
+112% +$356K
LCI
737
DELISTED
Lannett Company, Inc.
LCI
$718K 0.01%
20,350
-61,294
-75% -$2.49M
MDT icon
738
Medtronic
MDT
$107B
$712K 0.01%
6,273
+1,553
+33% +$170K
AAMI
739
Acadian Asset Management
AAMI
$2.88B
$712K 0.01%
69,659
-56,126
-45% -$548K
CLVS
740
DELISTED
Clovis Oncology, Inc.
CLVS
$708K 0.01%
67,951
-30,299
-31% -$220K
CMS icon
741
CMS Energy
CMS
$23.1B
$682K 0.01%
10,848
-1,056
-9% -$65.8K
FTK icon
742
Flotek Industries
FTK
$935M
$681K 0.01%
56,762
+46,095
+432% +$532K
CERS icon
743
Cerus
CERS
$587M
$674K 0.01%
+159,784
New +$689K
DTE icon
744
DTE Energy
DTE
$31.1B
$674K 0.01%
6,095
-15,631
-72% -$1.69M
HONE
745
DELISTED
HarborOne Bancorp
HONE
$673K 0.01%
61,208
+23,600
+63% +$247K
AVNS icon
746
Avanos Medical
AVNS
$1.17B
$671K 0.01%
19,918
-17,842
-47% -$646K
JWN
747
DELISTED
Nordstrom
JWN
$670K 0.01%
+16,360
New +$605K
MRLN
748
DELISTED
Marlin Business Services Corp
MRLN
$665K 0.01%
30,255
+4,121
+16% +$93.5K
SCSC icon
749
Scansource
SCSC
$1.12B
$664K 0.01%
17,963
-11,417
-39% -$388K
PEBO icon
750
Peoples Bancorp
PEBO
$1.45B
$657K 0.01%
18,943
+2,698
+17% +$88.3K

Similar funds

Jacobs Levy Equity Management's Q4 2019 Portfolio in Review

As of Q4 2019, Jacobs Levy Equity Management held 1,109 positions worth $10.2B, up 25% from $8.15B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Jacobs Levy Equity Management deployed $1.34B of net new capital in Q4 2019, opening 201 new positions and adding to 523 existing holdings. Its largest new stake was Athene Holding Ltd. Class A Common Shares: 551,505 shares worth $25.9M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Qualcomm, an estimated $76.7M trimmed.

  • Jacobs Levy Equity Management's largest Q4 2019 buy was Athene Holding Ltd. Class A Common Shares: 551,505 shares worth $25.9M.
  • Jacobs Levy Equity Management added most to AbbVie in Q4 2019, an estimated $57.2M increase.
  • Jacobs Levy Equity Management's biggest Q4 2019 reduction was Qualcomm, cutting an estimated $76.7M.
  • Jacobs Levy Equity Management fully exited NVR in Q4 2019, selling an estimated $49.7M.
  • Jacobs Levy Equity Management's ten largest holdings make up 17% of its $10.2B portfolio in Q4 2019.
  • Jacobs Levy Equity Management opened 201 new positions and closed 122 in Q4 2019.
  • Jacobs Levy Equity Management's portfolio value rose 25% quarter-over-quarter to $10.2B.

Based on Jacobs Levy Equity Management's 13F filing for Q4 2019, filed 14 Feb 2020.